• Profile
Close

GnRH agonist vs hCG to induce final oocyte maturation in patients at low risk of OHSS

Fertility and Sterility Mar 30, 2018

Green KA, et al. - The authors compared embryologic and clinical outcomes between gonadotropin-releasing hormone agonist (GnRHa) and hCG triggers in a patient population at low risk of ovarian hyperstimulation syndrome (OHSS). Analysis of a large number of GnRH antagonist in vitro fertilization (IVF) cycles suggested no impairment in outcomes among patients at low risk of OHSS after GnRHa trigger compared to hCG trigger. As per data, GnRHa trigger could improve some embryologic outcomes and live birth, though the absolute differences were small. It is possible that via an endogenous LH and FSH surge, a GnRHa trigger might benefit oocyte quality. However, no differences in % mature oocytes were evident. The data do not suggest a harm in using GnRHa trigger to patients at low risk of OHSS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay